Clinical outcomes of a twice-daily metronidazole dosing strategy for Bacteroides spp. bloodstream infections
In the largest study to date of patients with Bacteroides spp. bacteraemia treated with metronidazole, twice-daily dosing strategies were not associated with worse outcomes compared with thrice-daily dosing strategies.
Authors
- Jeffrey Topal (ORCID: https://orcid.org/0000-0003-4308-2352)
- Dayna McManus (ORCID: https://orcid.org/0000-0002-8153-3284)
- M. Hong Nguyen (ORCID: https://orcid.org/0000-0003-2065-3239)
- Sunish Shah (ORCID: https://orcid.org/0000-0002-8873-1451)
- Kathleen K. Adams (ORCID: https://orcid.org/0000-0002-8065-4754)
- Justin Ludwig (ORCID: https://orcid.org/0000-0002-4039-7722)
- Ryan K. Shields (ORCID: https://orcid.org/0000-0001-9794-5665)
- Lloyd Clarke
Institutions
- Yale New Haven Hospital (US)
- University of Connecticut (US)
- University of Pittsburgh (US)
- University of Pittsburgh Medical Center (US)
Publication Details
- Journal
- International Journal of Antimicrobial Agents
- Published
- 2024-12-10
- DOI
- https://doi.org/10.1016/j.ijantimicag.2024.107403
- Citations
- 3
- Primary Topic
- Bacterial Identification and Susceptibility Testing
- Type
- article
- Field-Weighted Citation Impact
- 1.14